Effects of a high-fiber diet on hepatocyte apoptosis and liver regeneration after partial hepatectomy in rats with fatty liver

Journal of Parenteral and Enteral Nutrition

Volumn 29, Issue 6, 2005, Pages 401-407

  Lai, Hong Shiee ^a   Lin, Wen His ^a   Chen, Pey Rong ^a   Wu, Hsiu Chuan ^a   Lee, Po Huang ^a   Chen, Wei Jao ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BROXURIDINE; CASPASE 3; ORNITHINE DECARBOXYLASE; CASP3 PROTEIN, RAT; CASPASE; DNA FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY LIVER; HIGH FIBER DIET; INSULIN SENSITIVITY; LIPID DIET; LIVER CELL; LIVER REGENERATION; LIVER RESECTION; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT; ANIMAL; BODY WEIGHT; CYTOLOGY; DIET THERAPY; DIETARY FIBER; DRUG EFFECT; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; LIVER; METABOLISM; ORGAN SIZE; PHYSIOLOGY; RANDOMIZATION; TIME; WISTAR RAT;

RATTUS NORVEGICUS;

ANIMALS; APOPTOSIS; BODY WEIGHT; BROMODEOXYURIDINE; CASPASE 3; CASPASES; DIETARY FIBER; DNA FRAGMENTATION; FATTY LIVER; HEPATECTOMY; LIVER; LIVER REGENERATION; MALE; ORGAN SIZE; ORNITHINE DECARBOXYLASE; RANDOM ALLOCATION; RATS; RATS, WISTAR; TIME FACTORS;

EID: 33645728656     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607105029006401     Document Type: Article

References (42)

1. Clarke SD. Nonalcoholic steatosis and steatohepatitis: molecular mechanism for polyunsaturated fatty acid regulation of gene transcription. Am J Physiol. 2001;281:G865-G869.
2. Gerloff BJ. Dry cow management for the prevention of ketosis and fatty liver in dairy cows. Vet Clin North Am. 2000;16:283-292.
3. Behrns KE, Tsiotos GG, De Souza NF, Krishna MK, Ludwig J, Nagomey DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg. 1998;2:292-298.
4. Chamuleau RAFM, Bosnian DK. Liver regeneration. Hepatogastroenterology. 1988;35:309-312.
5. Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997;276:60-66.
6. Lai HS, Chen WJ, Chen KM. Changes in T-lymphocyte subpopulations and serum lymphokine concentrations after partial hepatectomy in rats. Nutrition. 1996;12:700-705.
7. Lai HS, Chen Y, Chen WJ. Carnitine contents in remnant liver, kidney and skeletal muscle after partial hepatectomy in rats: randomized trial. World J Surg. 1998;22:42-47.
8. Picard C, Lambotte L, Starkel P, et al. Steatosis is not sufficient to cause an impaired regenerative response after partial hepatectomy in rats. J Hepatol. 2002;36:645-652.
9. Hussein O, Szvalb S, Van den Akker-Berman LM, Assy N. Liver regeneration is not altered in patients with nonalcoholic steato-hepatitis (NASH) when compared to chronic hepatitis C infection with similar grade of inflammation. Dig Dis Sci. 2002;47:1926-1931.
10. Torbenson M, Yang SQ, Liu HZ, Huang J, Gage W, Diehl AM. STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. Am J Pathol. 2002;161:155-161.
11. Farrell GC, Robertson GR, Leclercq I, Horsmans Y. Liver regeneration in obese mice with fatty livers: does the impairment have relevance for other types of fatty liver disease? Hepatology. 2002;35:731-732.
12. Bursch W, Oberhammer F, Schulte-Hermann R. Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci. 1992;13:245-251.
13. Yang S, Lin H, Diehl AM. Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation. Am J Physiol. 2001;281:G382-G392.
14. Musso G, Gambino R, De Michieli F, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology. 2003;37:909-916.
15. Barber AE, Jones WG, Minei JP, et al. Glutamine or fiber supplementation of a defined formula diet: impact on bacterial translocation, tissue composition, and response to endotoxin. JPEN J Parenter Enteral Nutr. 1990;14:335-343.
16. Higgins GM, Andersen RM. Experimental pathology of the liver. Arch Pathol. 1931;12:186-192.
17. WAF1/CIP1 in selenite-induced apoptosis of regenerating liver. Eur J Pharmacol. 2003;471:1-8.
18. Gratzner HG. Monoclonal antibody to 5-bromo- and 5-incodeoxyurine: a new reagent for detection of DNA replication. Science. 1982;218:475-476.
19. Schipper RG, Rutten RG, Sauerbeck M, et al. Preparation and characterization of monoclonal antibodies against ornithine decarboxylase. J Immunol Methods. 1993;161:205-215.
20. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 2001;21:3-16.
21. Li Z, Yang S, Lin H, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology. 2003;37:343-350.
22. Kushner RF. Medical management of obesity. Semin Gastrointest Dis. 2002;13:123-132.
23. Lindblad A, Glaumann H, Strandvik B. Natural history of liver disease in cystic fibrosis. Hepatology. 1999;30:1151-1158.
24. Itoh H, Ohshima S, Shumiya S, Sakaguchi E. Development of a diet for long-term raising of F344 rats: relationship between dietary digestible crude protein content and digestible energy content. Exp Anim. 2002;51:317-326.
25. Barzilai N, She L, Liu BQ, et al. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes. 1999;48:94-98.
26. Ye JM, Iglesias MA, Watson DG, et al. PPAR alpha/gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly. Am J Physiol. 2003;284:E531-E540.
27. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes. 1996;45:633-638.
28. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844-1850.
29. Schiffrin EL, Amiri F, Benkirane K, Iglarz M, Diep QN. Peroxisome proliferator-activated receptors: vascular and cardiac effects in hypertension. Hypertension. 2003;42:664-668.
30. Matteoni C, Younossi ZM, McCullough A. Nonalcoholic fatty liver disease: a spectrum of clinical pathological severity. Gastroenterology. 1999;116:1413-1419.
31. Crespo J, Cayon A, Fernandez-Gil P, et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology. 2001;34:1158-1163.
32. Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest. 2002;109:1345-1350.
33. Baroni GS, Marucci L, Benedetti A, Mancini R, Jezequel AM, Orlandi F. Chronic ethanol feeding increases apoptosis and cell proliferation in rat liver. J Hepatol. 1994;20:508-513.
34. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med. 2000;20:1467-1476.
35. Faloon WW. Hepatobiliary effects of obesity and weight-reducing surgery. Semin Liver Dis. 1988;8:229-236.
36. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A. 1997;94:2557-2562.
37. Susca M, Grassi A, Zauli D, et al. Liver inflammatory cells, apoptosis, regeneration and stellate cell activation in non-alcoholic steatohepatitis. Dig Liver Dis. 2001;33:768-777.
38. Ohnishi H, Muto Y, Maeda T, et al. Natural killer cell may impair liver regeneration in fulminant hepatic failure. Gastroenterol Jpn. 1993;28:40-44.
39. Vujanovic NL, Polimeno L, Azzarone A, et al. Changes of liver-resident NK cells during liver regeneration in rats. J Immunol. 1995;154:6324-6338.
40. McGowan JA, Fausto N. Ornithine decarboxylase activity and the onset of deoxyribonucleic acid synthesis in regenerating liver. Biochem J. 1977;170:123-127.
41. Kahn D, Svanas G, Eagon P, et al. Effect of an antiandrogenic H2 receptor antagonist on hepatic regeneration in rats. J Lab Clin Med. 1998;112:232-239.
42. Yang SQ, Lin HZ, Mandal AK, Huang J, Diehl AM. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology. 2001;34:694-706.